NTHI logo

Neonc Technologies Holdings, Inc.

NTHI
Healthcare|Biotechnology|US
$3.49
+0.29 (+9.06%)
Cash / Share
$0.24
Financing Filings (last 12 months)
12
Shelf registrations / offering prospectuses — latest Sep 10, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (4)

Nov 2026
Est. completion
P1P2Glioblastoma Multiforme
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
NCT02704858n=49
Dec 2026
Est. completion
P2Residual, Progressive or Recurrent Grade II or III Meningioma
NEO100 and High-Grade Meningioma
NCT05023018n=30
Feb 2027
Est. completion
P1P2Diffuse Astrocytoma, IDH-Mutant
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
NCT06047379n=134
Jun 2027
Est. completion
P1Pediatric Tumor of CNS
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
NCT06357377n=12

Recent Press Releases

NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Nov 5, 2026 · GlobeNewsWire
NeOnc Is Putting Two Brain Cancer Programs on the Global Stage
Nov 2, 2026 · GlobeNewsWire
NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology
Nov 2, 2026 · GlobeNewsWire
NeOnc's Ambitious Brain Cancer Plans are Setting the Stage
Oct 30, 2026 · GlobeNewsWire
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
Oct 26, 2026 · GlobeNewsWire
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue
Oct 23, 2026 · GlobeNewsWire
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight
Oct 22, 2026 · GlobeNewsWire
NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy
Oct 22, 2026 · GlobeNewsWire
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches
Oct 21, 2026 · Newsfile Corp
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
Oct 21, 2026 · GlobeNewsWire

SEC Filings (107)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 3, 20268-KMaterial eventDocumentIndex
Oct 22, 20268-KMaterial eventDocumentIndex
Oct 15, 20268-KMaterial eventDocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Sep 21, 20268-KMaterial eventDocumentIndex
Sep 17, 20268-KMaterial eventDocumentIndex
Sep 10, 20268-KMaterial eventDocumentIndex
Sep 10, 2026424B5Offering prospectusDocumentIndex
Aug 21, 20268-K/AMaterial eventDocumentIndex
Aug 20, 20268-KMaterial eventDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Aug 10, 20268-KMaterial eventDocumentIndex
Aug 10, 202610-QQuarterly reportDocumentIndex
Jul 15, 20268-KMaterial eventDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jun 25, 2026DDocumentIndex
Jun 23, 2026EFFECTDocumentIndex
Jun 23, 2026DEFA14AProxy / shareholder voteDocumentIndex
Jun 23, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
Jun 23, 2026424B5Offering prospectusDocumentIndex
Jun 18, 20268-KMaterial eventDocumentIndex
Jun 15, 2026S-3Shelf registrationDocumentIndex
Jun 12, 20268-KMaterial eventDocumentIndex
Jun 11, 2026PRE 14AProxy / shareholder voteDocumentIndex
May 18, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 5, 202610-K/AAnnual reportDocumentIndex
Apr 24, 20268-KMaterial eventDocumentIndex
Apr 16, 2026EFFECTDocumentIndex
Apr 16, 20268-KMaterial eventDocumentIndex
Apr 16, 2026424B5Offering prospectusDocumentIndex
Apr 10, 2026S-3Shelf registrationDocumentIndex
Apr 10, 20268-KMaterial eventDocumentIndex
Apr 10, 2026424B5Offering prospectusDocumentIndex
Apr 9, 2026EFFECTDocumentIndex